Literature DB >> 10406582

Incidence of pulmonary thromboembolism in Japan.

N Kumasaka1, M Sakuma, K Shirato.   

Abstract

Pulmonary thromboembolism (PTE) is considered an uncommon disease in Japan and there are not any reported prospective studies on the incidence of PTE in Japan. The objective of the present study was to determine the number of patients with PTE per year in a prospective study using a questionnaire. Letters were sent to clinical departments in university schools of medicine or medical colleges, and to hospitals with more than 100 beds. The diagnosis of PTE was to be confirmed by (1) pulmonary artery stenosis or occlusion on pulmonary angiography, (2) mismatch of pulmonary perfusion scintigraphy and pulmonary ventilation scintigraphy, (3) changes on pulmonary perfusion scintigraphy performed twice, or (4) autopsy. The questionnaire elicited 2,341 replies (the withdrawal rate was 40.7%). In 231 hospitals, 237 patients were diagnosed definitely during the study period of 2 months from 1 August to 30 September 1996. From this it was estimated that there are 3,492 (95% confidence interval: 3,280-3,703) patients with PTE per year, which implies that the incidence is 28 persons per 1,000,000 people per year, confirming that PTE is rare in Japan.

Entities:  

Mesh:

Year:  1999        PMID: 10406582     DOI: 10.1253/jcj.63.439

Source DB:  PubMed          Journal:  Jpn Circ J        ISSN: 0047-1828


  10 in total

1.  Pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor ximelagatran in young healthy Japanese men.

Authors:  Linda C Wernevik; Per Nyström; Gillis Johnsson; Takashi Nakanishi; Ulf G Eriksson
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

2.  Review of acute pulmonary embolism in a general hospital.

Authors:  Keiichi Ishida; Masahisa Masuda
Journal:  Surg Today       Date:  2007-08-27       Impact factor: 2.549

3.  Incidence and prevention of postoperative venous thromboembolism: are they meaningful quality indicators in Japanese health care settings?

Authors:  Susumu Kunisawa; Hiroshi Ikai; Yuichi Imanaka
Journal:  World J Surg       Date:  2012-02       Impact factor: 3.352

4.  Epidemiological and outcome data in Japanese patients with deep vein thrombosis with and without malignancy.

Authors:  Kensuke Yokoi; Masahiko Hara; Yasunori Ueda; Keiichi Yamamoto; Keiko Ota; Daijiro Kabata; Tetsuhisa Kitamura; Yasushi Sakata; Ayumi Shintani
Journal:  Heart Vessels       Date:  2017-07-24       Impact factor: 2.037

5.  Diagnostic Imaging of Pulmonary Thromboembolism by Multidetector-row CT.

Authors:  Hiromitsu Hayashi; Tomonari Kiriyama; Masato Shiiba; Masaki Tachi; Tomoyuki Kuwako; Tatsuo Ueda; Hidenori Yamagguchi; Tetsuro Sekine; Yasuhiro Kobayashi; Ryo Takagi; Shin-Ichiro Kumita
Journal:  Ann Vasc Dis       Date:  2010-12-25

Review 6.  Recent advances of pulmonary endarterectomy for chronic thromboembolic pulmonary hypertension including Japanese experiences.

Authors:  Hitoshi Ogino
Journal:  Gen Thorac Cardiovasc Surg       Date:  2013-09-26

Review 7.  Safety of antithrombotic therapy in East Asian patients.

Authors:  Shinya Goto; Shinichi Goto
Journal:  Intern Emerg Med       Date:  2021-03-08       Impact factor: 3.397

8.  Intermittent pneumatic compression for prevention of pulmonary thromboembolism after gynecologic surgery.

Authors:  Nao Suzuki; Fumio Kataoka; Atsushi Higashiguchi; Takeshi Hirao; Sachiko Ezawa; Hiroyuki Nomura; Akiyo Tomita; Nobuyuki Susumu; Daisuke Aoki
Journal:  Thromb J       Date:  2005-11-19

9.  Rationale, Design, and Baseline Characteristics of the BioProsthetic Valves with Atrial Fibrillation (BPV-AF) Study.

Authors:  Yutaka Furukawa; Makoto Miyake; Tomoyuki Fujita; Tadaaki Koyama; Misa Takegami; Tetsuya Kimura; Kumiko Sugio; Atsushi Takita; Kunihiro Nishimura; Chisato Izumi
Journal:  Cardiovasc Drugs Ther       Date:  2020-07-24       Impact factor: 3.727

10.  Incidence of venous thromboembolism in psychiatric inpatients: a chart review.

Authors:  Masahiro Takeshima; Hiroyasu Ishikawa; Kazumi Shimizu; Takashi Kanbayashi; Tetsuo Shimizu
Journal:  Neuropsychiatr Dis Treat       Date:  2018-05-23       Impact factor: 2.570

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.